Viewing Study NCT05094804


Ignite Creation Date: 2025-12-24 @ 9:09 PM
Ignite Modification Date: 2026-01-04 @ 3:43 PM
Study NCT ID: NCT05094804
Status: UNKNOWN
Last Update Posted: 2023-11-02
First Post: 2021-09-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
Sponsor: OncoResponse, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module